The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

Drug Intelligence & Clinical Pharmacy: Vol. 22, No. 6, pp. 443-451.
© 1988 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weidle, P.
Right arrow Articles by Vlasses, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weidle, P.
Right arrow Articles by Vlasses, P.

Research Articles

Systemic hypertension associated with cyclosporine: a review

PJ Weidle and PH Vlasses

Use of the immunosuppressive agent cyclosporine has been associated with an increased incidence of hypertension. The incidence, onset, duration, and severity of the associated blood pressure elevation varies greatly depending on the therapeutic indication for cyclosporine use. This paper reviews the disparity in the reports of cyclosporine-associated hypertension and the factors evaluated for possible association. Possible mechanisms involved in the blood pressure elevation as well as treatment approaches that have been employed are discussed. Further research efforts are needed to clarify conflicting information regarding mechanisms, associated factors, and rational treatment.


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
M. Tomasiak, T. Rusak, M. Gacko, and H. Stelmach
Cyclosporine enhances platelet procoagulant activity
Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1750 - 1756.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
D.-H. Kang, Y.-G. Kim, T. F. Andoh, K. L. Gordon, S.-I. Suga, M. Mazzali, J. A. Jefferson, J. Hughes, W. Bennett, G. F. Schreiner, et al.
Post-cyclosporine-mediated hypertension and nephropathy: amelioration by vascular endothelial growth factor
Am J Physiol Renal Physiol, April 1, 2001; 280(4): F727 - F736.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
J. Feenstra, D. E. Grobbee, W. J. Remme, and B. H. C. Stricker
Drug-induced heart failure
J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1152 - 1162.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
H. J. Oskarsson, T. G. Hofmeyer, and M. T. Olivari
Cyclosporine Impairs the Ability of Human Platelets to Mediate Vasodilation
Hypertension, June 1, 1997; 29(6): 1314 - 1321.
[Abstract] [Full Text]

Home page
 ANN INTERN MEDHome page
G. Deray, M. Benhmida, P. Le Hoang, P. Maksud, B. Aupetit, A. Baumelou, and C. Jacobs
Renal Function and Blood Pressure in Patients Receiving Long-Term, Low-Dose Cyclosporine Therapy for Idiopathic Autoimmune Uveitis
Ann Intern Med, October 1, 1992; 117(7): 578 - 583.
[Abstract] [PDF]

Home page
 ANN INTERN MEDHome page
Working Group on Management of Patients with Hyper
National Education Programs Working Group Report on the Management of Patients with Hypertension and High Blood Cholesterol
Ann Intern Med, February 1, 1991; 114(3): 224 - 237.
[Abstract] [PDF]

Home page
 Arch Intern MedHome page
G. A. Porter, W. M. Bennett, and S. G. Sheps
Cyclosporine-Associated Hypertension
Arch Intern Med, February 1, 1990; 150(2): 280 - 283.
[Abstract] [PDF]


homecopy help contact us subscription past issues search current issue
Copyright © 1988 by Harvey Whitney Books Company.